Recombinant lysostaphin (Bharat Biotechnologies)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant lysostaphin (Bharat Biotechnologies)
Drug Alias Name溶葡球菌酶（Bharat Biotechnologies）BBIL-5
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBharat Biotech International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBharat Biotech International Ltd
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A